Early studies of ARL reported associations of a poor prognosis with multiple factors, including patient-specific (age and performance status), HIV-specific (history of AIDS, and low CD4+ count), and lymphoma-specific factors (stage, lactate dehydrogenase [LDH] levels, extranodal disease, and a high international prognostic index [IPI])13,14. Here, CD4 is linked to AIDS.